Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy.

International audience

Data and Resources

Additional Info

Field Value
Source ISSN: 0950-9232
Author Leconet, Wilhem, Larbouret, Christel, Chardès, Thierry, Thomas, Gaëlle, Neiveyans, Madeline, Busson, Muriel, Jarlier, Marta, Radosevic-Robin, Nina, Pugnière, Martine, Bernex, Florence, Penault-Llorca, Frédérique, Pasquet, Jean-Max, Pèlegrin, André, Robert, Bruno
Maintainer CCSD
Last Updated May 7, 2026, 21:07 (UTC)
Created May 7, 2026, 21:07 (UTC)
Identifier inserm-00916587
Language en
Rights https://about.hal.science/hal-authorisation-v1/
contributor Institut de recherche en cancérologie de Montpellier (IRCM - U896 Inserm - UM1) ; Université Montpellier 1 (UM1)-CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)
creator Leconet, Wilhem
date 2014-11-20T00:00:00
harvest_object_id 8c1a699d-5f1c-4939-8e00-439acf5f9884
harvest_source_id 3374d638-d20b-4672-ba96-a23232d55657
harvest_source_title test moissonnage SELUNE
metadata_modified 2026-01-04T00:00:00
relation info:eu-repo/semantics/altIdentifier/doi/10.1038/onc.2013.487
set_spec type:ART